# CAMP (CAMP4 Therapeutics Corporation) - SEC EDGAR Financial Statements

> CAMP4 Therapeutics Corporation reported $5.32M in revenue and a net loss of $121.1M for the trailing twelve months ended September 30, 2026 (up 138.9% year over year), with a -1001.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/CAMP
- Markdown: https://convexityos.com/fundamentals/CAMP.md
- SEC CIK: 0001736730
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:42 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001736730&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $5.32M | +138.9% YoY |
| Operating Income | TTM | -$53.26M | -1001.1% margin |
| Net Income | TTM | -$121.1M | -2276.3% net margin |
| Diluted EPS | TTM | -$1.53 | Split-adjusted |
| Free Cash Flow | TTM | -$26.41M | -496.4% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $124.5M | Total debt: $6.45M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $3.50M | $652K | $350K |
| Research & Development | $38.20M | $38.82M | $40.62M |
| Total Operating Expenses | $56.05M | $53.74M | $52.23M |
| **Operating Income** | -$52.55M | -$53.09M | -$51.88M |
| **EBITDA** | -$50.92M | -$51.39M | -$50.20M |
| Interest Income | $2.17M | $1.33M | $2.81M |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | -$80.40M | -$51.79M | -$49.29M |
| Basic EPS | -$2.65 | -$11.04 | -$124.80 |
| **Diluted EPS** | -$2.65 | -$11.04 | -$124.80 |
| Basic Shares Outstanding | 30.4M | 4.7M | 395.0K |
| Diluted Shares Outstanding | 30.4M | 4.7M | 395.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.90M | $1.78M | $1.29M | $348K | $795K | $1.50M | $858K | -- |
| Research & Development | $11.43M | $10.82M | $10.16M | $7.86M | $9.85M | $10.34M | $10.15M | $10.00M |
| Total Operating Expenses | $15.93M | $15.16M | $14.37M | $13.12M | $14.45M | $14.53M | $13.96M | $14.69M |
| **Operating Income** | -$14.03M | -$13.38M | -$13.07M | -$12.78M | -$13.65M | -$13.03M | -$13.10M | -$14.03M |
| **EBITDA** | -$13.51M | -$12.87M | -$12.55M | -$12.40M | -$13.23M | -$12.60M | -$12.68M | -$13.62M |
| Interest Income | $984K | $807K | $910K | $710K | $423K | $453K | $588K | $610K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$28.96M | -$33.53M | -$18.33M | -$40.28M | -$15.10M | -$12.59M | -$12.43M | -$13.28M |
| Basic EPS | -$0.37 | -$0.58 | -$0.32 | -- | -$0.55 | -$0.62 | -$0.62 | -- |
| **Diluted EPS** | -$0.37 | -$0.58 | -$0.32 | -- | -$0.55 | -$0.62 | -$0.62 | -- |
| Basic Shares Outstanding | 78.9M | 57.9M | 57.9M | -- | 27.3M | 20.2M | 20.2M | -- |
| Diluted Shares Outstanding | 78.9M | 57.9M | 57.9M | -- | 27.3M | 20.2M | 20.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $109.5M | $64.04M | $38.38M |
| **Cash & Short-Term Investments** | $109.5M | $64.04M | $38.38M |
| Other Current Assets | $342K | $211K | $245K |
| **Total Current Assets** | $114.1M | $66.38M | $40.01M |
| Property, Plant & Equipment, Net | $2.34M | $3.86M | $4.80M |
| Other Non-Current Assets | $83K | $427K | -- |
| **Total Non-Current Assets** | $3.71M | $11.92M | $14.93M |
| **Total Assets** | $117.8M | $78.31M | $54.95M |
| Accounts Payable | $182K | $1.21M | $1.04M |
| Deferred Revenue (Current) | $9.39M | $385K | $0 |
| Other Current Liabilities | $27K | $176K | -- |
| **Total Current Liabilities** | $15.51M | $9.60M | $7.81M |
| Deferred Revenue (Non-Current) | $8.11M | $0 | -- |
| Other Non-Current Liabilities | $29K | $72K | $2.0K |
| **Total Non-Current Liabilities** | $54.59M | $5.57M | $8.72M |
| **Total Liabilities** | $70.10M | $15.16M | $16.53M |
| **Total Debt (incl. Leases)** | $1.97M | $8.65M | $11.69M |
| Common Stock | $6.0K | $2.0K | $1.0K |
| Retained Earnings | -$292.2M | -$211.8M | -$160.0M |
| **Total Stockholders' Equity** | $47.70M | $63.14M | -$123.7M |
| Total Equity | $47.70M | $63.14M | -$123.7M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $124.5M | $86.40M | $99.21M | $109.5M | $75.25M | $39.05M | $49.32M | $64.04M |
| **Cash & Short-Term Investments** | $124.5M | $86.40M | $99.21M | $109.5M | $75.25M | $39.05M | $49.32M | $64.04M |
| Other Current Assets | $240K | $331K | $388K | $342K | $204K | $333K | $362K | $211K |
| **Total Current Assets** | $127.5M | $90.03M | $102.2M | $114.1M | $77.71M | $41.09M | $51.67M | $66.38M |
| Property, Plant & Equipment, Net | $1.68M | $1.85M | $1.93M | $2.34M | $2.90M | $3.41M | $3.60M | $3.86M |
| Other Non-Current Assets | $61K | $68K | $76K | $83K | -- | -- | -- | $427K |
| **Total Non-Current Assets** | $6.48M | $3.40M | $3.26M | $3.71M | $8.69M | $10.19M | $11.10M | $11.92M |
| **Total Assets** | $134.0M | $93.43M | $105.5M | $117.8M | $86.39M | $51.27M | $62.77M | $78.31M |
| Accounts Payable | $760K | $1.09M | $863K | $182K | $585K | $1.20M | $1.40M | $1.21M |
| Deferred Revenue (Current) | $10.50M | $13.01M | $11.07M | $9.39M | $0 | $0 | $0 | $385K |
| Other Current Liabilities | -- | -- | -- | $27K | -- | -- | -- | $176K |
| **Total Current Liabilities** | $19.86M | $19.14M | $16.62M | $15.51M | $7.90M | $7.33M | $6.44M | $9.60M |
| Deferred Revenue (Non-Current) | $2.18M | $1.50M | $5.21M | $8.11M | -- | -- | -- | $0 |
| Other Non-Current Liabilities | $49K | $31K | $30K | $29K | -- | $2.0K | $2.0K | $72K |
| **Total Non-Current Liabilities** | $7.05M | $74.98M | $57.93M | $54.59M | $19.82M | $3.95M | $4.76M | $5.57M |
| **Total Liabilities** | $26.92M | $94.12M | $74.56M | $70.10M | $27.73M | $11.29M | $11.20M | $15.16M |
| **Total Debt (incl. Leases)** | $6.45M | $2.37M | $2.12M | $1.97M | $6.35M | $7.12M | $7.87M | $8.65M |
| Common Stock | $7.0K | $6.0K | $6.0K | $6.0K | $5.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$373.0M | -$344.0M | -$310.5M | -$292.2M | -$251.9M | -$236.8M | -$224.2M | -$211.8M |
| **Total Stockholders' Equity** | $107.1M | -$693K | $30.90M | $47.70M | $58.67M | $39.99M | $51.57M | $63.14M |
| Total Equity | $107.1M | -$693K | $30.90M | $47.70M | $58.67M | $39.99M | $51.57M | $63.14M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$80.40M | -$51.79M | -$49.29M |
| Depreciation & Amortization | $1.64M | $1.70M | $1.68M |
| Stock-Based Compensation | $4.00M | $4.03M | $2.91M |
| Change in Payables | -$1.03M | $168K | -$1.11M |
| **Operating Cash Flow** | -$29.55M | -$45.56M | -$44.16M |
| Capital Expenditure | -$279K | -$441K | -$678K |
| **Free Cash Flow** | -$29.83M | -$46.00M | -$44.83M |
| **Investing Cash Flow** | -$243K | -$441K | -$678K |
| Common Stock Issued | $57.52M | $76.35M | $0 |
| **Financing Cash Flow** | $75.89M | $71.66M | $301K |
| **Net Change in Cash** | $46.09M | $25.66M | -$44.53M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$28.96M | -$33.53M | -$18.33M | -$40.28M | -$15.10M | -$12.59M | -$12.43M | -$13.28M |
| Depreciation & Amortization | $523K | $515K | $520K | $372K | $416K | $430K | $421K | $418K |
| Stock-Based Compensation | $2.02M | $1.93M | $1.47M | $1.15M | $984K | $1.00M | $861K | $797K |
| Change in Payables | -$346K | $319K | $592K | -$467K | -$546K | -$190K | $175K | -$856K |
| **Operating Cash Flow** | -$8.16M | -$12.69M | -$10.98M | $6.29M | -$11.22M | -$10.34M | -$14.29M | -$11.29M |
| Capital Expenditure | -$740K | -$129K | $0 | $0 | $0 | $0 | -$279K | -$263K |
| **Free Cash Flow** | -$8.90M | -$12.81M | -$10.98M | $6.29M | -$11.22M | -$10.34M | -$14.56M | -$11.55M |
| **Investing Cash Flow** | -$740K | -$129K | $0 | $0 | $36K | $0 | -$279K | -$263K |
| Common Stock Issued | -- | -- | -- | $28.55M | $28.96M | $0 | $0 | $76.32M |
| **Financing Cash Flow** | $47.03M | $4.0K | $57K | $28.59M | $47.38M | $72K | -$151K | $73.06M |
| **Net Change in Cash** | $38.12M | -$12.81M | -$10.92M | $34.88M | $36.20M | -$10.27M | -$14.72M | $61.51M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Operating Margin** | -1502.4% | -8142.3% | -14822.6% |
| **Net Profit Margin** | -2298.5% | -7943.4% | -14083.1% |
| Return on Equity (ROE) | -168.5% | -82.0% | -- |
| Return on Assets (ROA) | -68.2% | -66.1% | -89.7% |
| Current Ratio | 7.35x | 6.92x | 5.13x |
| Quick Ratio | 7.06x | 6.67x | 4.92x |
| Debt to Equity | 0.04x | 0.14x | -- |
| **Revenue Growth (YoY)** | +436.5% | +86.3% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1001.1% | -1254.2% | -1335.2% | -1502.4% | -- | -- | -- | -- |
| **Net Profit Margin** | -2276.3% | -2543.7% | -2193.7% | -2298.5% | -- | -- | -- | -- |
| Return on Equity (ROE) | -113.1% | -- | -279.3% | -168.5% | -91.0% | -129.5% | -100.4% | -82.0% |
| Return on Assets (ROA) | -90.4% | -114.8% | -81.8% | -68.2% | -61.8% | -101.0% | -82.5% | -66.1% |
| Current Ratio | 6.42x | 4.70x | 6.15x | 7.35x | 9.83x | 5.60x | 8.02x | 6.92x |
| Quick Ratio | 6.27x | 4.51x | 5.97x | 7.06x | 9.52x | 5.32x | 7.66x | 6.67x |
| Debt to Equity | 0.06x | -- | 0.07x | 0.04x | 0.11x | 0.18x | 0.15x | 0.14x |
| **Revenue Growth (YoY)** | +138.9% | +18.8% | +50.8% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
